4//SEC Filing
Xenon Pharmaceuticals Inc. 4
Accession 0001171843-17-001505
$XENECIK 0001582313operating
Filed
Mar 13, 8:00 PM ET
Accepted
Mar 14, 4:25 PM ET
Size
5.4 KB
Accession
0001171843-17-001505
Insider Transaction Report
Form 4
GOLDBERG Y. PAUL
VP of Clinical Development
Transactions
- Award
Stock Option (Right to Buy)
2017-03-13+27,500→ 27,500 totalExercise: $8.40Exp: 2027-03-12→ Common Shares (27,500 underlying)
Footnotes (1)
- [F1]Vesting 25% on January 1, 2018, and 75% vesting thereafter over the course of the next 3 years, in equal amounts, on the last day of each month.
Documents
Issuer
Xenon Pharmaceuticals Inc.
CIK 0001582313
Entity typeoperating
IncorporatedBritish Columbia, Canada
Related Parties
1- filerCIK 0001582313
Filing Metadata
- Form type
- 4
- Filed
- Mar 13, 8:00 PM ET
- Accepted
- Mar 14, 4:25 PM ET
- Size
- 5.4 KB